Takura, Tomoyuki
Yuasa, Akira http://orcid.org/0000-0002-3699-7231
Yonemoto, Naohiro
Demiya, Sven
Matsuda, Hiroyuki
Ebata, Nozomi
Fujii, Koichi
Ishijima, Muneaki
Article History
Accepted: 19 July 2021
First Online: 10 August 2021
Declarations
:
: Pfizer Japan Inc. was the only direct sponsor of this study and fees were paid to IQVIA Solutions Japan K.K.
: Tomoyuki Takura received an advisory fee from Pfizer Japan Inc. Akira Yuasa, Naohiro Yonemoto, Nozomi Ebata and Koichi Fujii are full-time employees of Pfizer Japan Inc., and stockholders in Pfizer Inc. Sven Demiya and Hiroyuki Matsuda are full-time employees of IQVIA Solutions Japan K.K. Muneaki Ishijima has been on the speakers’ bureau for Pfizer Japan Inc.
: The data set used for the analysis was gathered from various public domains of the agencies (i.e., Ministry of Health, Labour and Welfare of Japan, Bank of Japan, Organisation for Economic Co-operation and Development, and The World Bank) and hence is publicly available, but is also available from the corresponding author upon reasonable request. Standard statistical functions were used in R and no additional software code was developed.
: Not applicable.
: Not applicable.
: All named authors meet the ICMJE criteria for authorship for this manuscript, take responsibility for the integrity of the work and have given final approval for this version of the manuscript to be published. All named authors contributed to the study design, model construction and reviewing of the manuscript.